PhoenixBio Co., Ltd. (6190.T)
JPY 335.0
(-1.76%)
JPY 335.0
(-1.76%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 26.37 Million JPY | -94.65% |
| 2022 | 493.32 Million JPY | 227.16% |
| 2021 | -387.97 Million JPY | -63.01% |
| 2020 | -238 Million JPY | 42.65% |
| 2019 | -415 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 23 Million JPY | 91.75% |
| 2023 Q2 | -14.5 Million JPY | -134.42% |
| 2023 Q4 | 11.99 Million JPY | 190.58% |
| 2023 Q3 | -13.24 Million JPY | 8.68% |
| 2023 FY | 26.37 Million JPY | -94.65% |
| 2023 Q1 | 42.12 Million JPY | -57.66% |
| 2022 Q2 | 253.54 Million JPY | 0.0% |
| 2022 FY | 493.32 Million JPY | 227.16% |
| 2022 Q4 | 99.5 Million JPY | 169.71% |
| 2022 Q3 | 36.89 Million JPY | -85.45% |
| 2021 FY | -387.97 Million JPY | -63.01% |
| 2020 FY | -238 Million JPY | 42.65% |
| 2019 FY | -415 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 93.131% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | 105.006% |
| GNI Group Ltd. | 8.09 Billion JPY | 99.674% |
| Linical Co., Ltd. | 338.26 Million JPY | 92.202% |
| Trans Genic Inc. | 4.08 Million JPY | -545.728% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 101.834% |
| Soiken Holdings Inc. | -662.2 Million JPY | 103.983% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 80.907% |
| AnGes, Inc. | -7.43 Billion JPY | 100.355% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 102.048% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 100.367% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 85.871% |
| NanoCarrier Co., Ltd. | -780 Million JPY | 103.382% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 102.288% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 102.182% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | 103.247% |
| RaQualia Pharma Inc. | -323.66 Million JPY | 108.15% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 102.162% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 101.855% |
| PeptiDream Inc. | 3.03 Billion JPY | 99.131% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 101.361% |
| Ribomic Inc. | -1.02 Billion JPY | 102.575% |
| SanBio Company Limited | -2.64 Billion JPY | 100.998% |
| Healios K.K. | -3.82 Billion JPY | 100.69% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 102.258% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 101.771% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 101.845% |
| StemRIM | -2.02 Billion JPY | 101.305% |
| CellSource Co., Ltd. | 923.14 Million JPY | 97.143% |
| FunPep Company Limited | -933.41 Million JPY | 102.826% |
| Kringle Pharma, Inc. | -854.15 Million JPY | 103.088% |
| Stella Pharma Corporation | -763.74 Million JPY | 103.454% |
| TMS Co., Ltd. | -960.04 Million JPY | 102.748% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 102.334% |
| Cuorips Inc. | -632.18 Million JPY | 104.173% |
| K Pharma,Inc. | 260.33 Million JPY | 89.867% |
| Takara Bio Inc. | 1.48 Billion JPY | 98.218% |
| ReproCELL Incorporated | -31.41 Million JPY | 183.966% |
| StemCell Institute Inc. | 310.98 Million JPY | 91.518% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 81.576% |
| CellSeed Inc. | -846.53 Million JPY | 103.116% |